| GFFFX | PGBEX | GFFFX / PGBEX | |
| Total Expense Ratio | 0.40 | 1.13 | 35% |
| Annual Report Gross Expense Ratio | 0.40 | 1.16 | 34% |
| Fund Existence | 17 years | 10 years | - |
| Gain YTD | 9.236 | -9.201 | -100% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 339B | 9.91B | 3,419% |
| Annual Yield % from dividends | 0.49 | 0.00 | - |
| Returns for 1 year | 6.03 | -11.50 | -52% |
| Returns for 3 years | 67.67 | 47.23 | 143% |
| Returns for 5 years | 23.69 | 18.45 | 128% |
| Returns for 10 years | 96.62 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CICAX | 62.96 | 0.03 | +0.05% |
| American Funds Invmt Co of Amer 529A | |||
| QILGX | 43.06 | 0.01 | +0.02% |
| Federated Hermes MDT Large Cap Growth IS | |||
| FPHAX | 32.21 | N/A | N/A |
| Fidelity Select Pharmaceuticals Port | |||
| GMCUX | 16.99 | N/A | N/A |
| Goldman Sachs Small/Mid Cap Equity R6 | |||
| VBCVX | 16.81 | -0.02 | -0.12% |
| VALIC Company I Systematic Value | |||